# SAR407899 Single-dose in Treatment of Mild to Moderate Erectile Dysfunction

> **NCT00914277** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 24 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** SAR407899
- **DRUG:** Placebo
- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT00914277
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-09
- **Final completion:** 2009-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914277, "SAR407899 Single-dose in Treatment of Mild to Moderate Erectile Dysfunction". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00914277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*